Showing 2671-2680 of 18644 results for "".
Quality of Life for Older People With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/quality-of-life-for-older-people-with-epilepsy/32178/Focusing on all aspects of health and well-being when treating older adults with epilepsy is important for improving quality of life.The Impact of Pharmacy Issues in Long-Term Care
https://reachmd.com/programs/advances-in-long-term-care-medicine/the-impact-of-pharmacy-issues-in-long-term-care/5896/As medication costs continue rising, what strategies can help long-term care facilities reduce drug expenditures, while still providing the best quality of care for patients? Fred Wendt, RPh, vice president of pharmacy services for Senior PharmaStrategies in Burleson, Texas, says one of the most sigFluid Foundations: How Location Impacts Outcomes in nAMD
https://reachmd.com/programs/cme/Fluid-Foundations-How-Location-Impacts-Outcomes-in-nAMD-2510/33126/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
https://reachmd.com/programs/cme/looking-ahead-integrating-cdh6-targeted-therapies-into-ovarian-cancer-treatment-paradigms/37866/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerDifferentiating First-Line Treatment Selection: Combination Immunotherapy and Chemotherapy Regimens for Metastatic ESCC
https://reachmd.com/programs/cme/differentiating-first-line-treatment-selection-combination-immunotherapy-and-chemotherapy-regimens-for-metastatic-escc/29167/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
https://reachmd.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-braf-mutant-stage-iv-melanoma/36328/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Improvement in health outcomes with GLP-1RA in patients with overweight or obesity with CVD
https://reachmd.com/cme/obesity/improvement-in-health-outcomes-with-glp-1ra-in-patients-with-overweight-or-obesity-with-cvd/17779/3' education - Nov. 11, 2023 - Ania Jastreboff, MD, PhDEmerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://reachmd.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://reachmd.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
https://reachmd.com/programs/cme/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.